欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (11): 1536-1540.doi: 10.12092/j.issn.1009-2501.2025.11.011

• 药物治疗学 • 上一篇    下一篇

舒更葡糖钠复合格隆溴铵、新斯的明在术中神经电生理监测时逆转肌松作用的半数有效剂量

金晶星1,梅凤美1,赵金兵2,曾琼1   

  1. 1南京医科大学附属脑科医院麻醉科,南京  210029,江苏;2南京医科大学附属脑科医院神经外科,南京  210029,江苏 
  • 收稿日期:2024-11-19 修回日期:2024-12-23 出版日期:2025-11-26 发布日期:2025-12-04
  • 通讯作者: 曾琼,女,硕士研究生,副主任医师,主要从事神经外科麻醉,脑保护研究。 E-mail: zengqiongnju@163.com
  • 作者简介:金晶星,女,硕士研究生,主治医师,主要从事神经外科的麻醉研究。 E-mail: 4602461@qq.com
  • 基金资助:
    江苏省卫生健康委2023年度医学科研项目(M2023223);南京市卫生科技发展专项资金项目(YKK22136)

Median effective dose (ED50) of sugammadex combined with glycopyrrolate and neostigmine in reversing muscle relaxation during intraoperative neurophysiological monitoring

JIN Jingxing1, MEI Fengmei1, ZHAO Jinbing2, ZENG Qiong1   

  1. 1Department of Anesthesiology, Brain Hospital Affiliated To Nanjing Medical University, Nanjing 210029, Jiangsu, China; 2Department of Neurosurgery, Brain Hospital Affiliated To Nanjing Medical University, Nanjing 210029, Jiangsu, China
  • Received:2024-11-19 Revised:2024-12-23 Online:2025-11-26 Published:2025-12-04

摘要:

目的:探讨小剂量舒更葡糖钠复合格隆溴铵、新斯的明在术中神经电生理监测时逆转肌松的半数有效剂量(ED50)。方法:选择择期在本院行全身麻醉下桥小脑角区肿瘤切除手术的患者36例,ASA Ⅱ或Ⅲ级,年龄18~80岁,BMI 20~30 kg/m2。麻醉诱导给予罗库溴铵0.60 mg/kg,四个成串刺激(train of four stimulation,TOF)为0后行气管插管。术中肌松维持罗库溴胺泵注,进行神经电生理监测时,停止泵注罗库溴铵,TOF恢复到T2出现时静注舒更葡糖钠初始剂量为1 mg/kg复合格隆溴铵4 μg/kg、新斯的明0.02 mg/kg,3 min内能诱发出电生理波形为有效剂量,反之则无效,下一个患者按照序贯法推荐使用初始剂量的20%作为相邻剂量增减的梯度上调或下调一个浓度,直到出现8个剂量转折点时结束研究。采用SPSS 20.0软件,用Probit回归模型计算ED50和95%可信区间(95%CI)。同时记录给药后前(T0)及使用后1 min(T1)、3 min(T2)、5 min(T3)的心率(HR),平均动脉压(MAP),术中知晓,体动发生率,电生理监测满意度。结果:共计36例患者纳入分析,Probit回归模型计算ED50为1.338 mg/kg,95%CI为0.838~1.786 mg/kg。给药后血流动力学稳定,神经电生理监测医生满意度为4.5±0.4,无术中知晓和体动发生。结论:小剂量舒更葡糖钠复合格隆溴铵、新斯的明在术中神经电生理监测时逆转肌松能监测到电生理波形的ED50为1.338 mg/kg,95%CI为0.838~1.786 mg/kg。

关键词: 舒更葡糖钠, 格隆溴铵, 新斯的明, 神经电生理, 半数有效剂量

Abstract:

AIM: To investigate the median effective dose (ED50) of low-dose sugammadex combined with glycopyrrolate and neostigmine in reversing muscle relaxation during intraoperative neurophysiological monitoring. METHODS: Thirty six patients with ASA grade II or III, aged between 18 and 80 years, were selected for elective resection of tumors in the cerebellopontine angle region under general anesthesia in our hospital, BMI 20-30 kg/m2. Anesthesia induction was administered with 0.60 mg/kg rocuronium bromide, and tracheal intubation was performed after TOF was 0. During the operation, muscle relaxation was maintained by pumping rocuronium bromide. When performing neurophysiological monitoring, the pumping of rocuronium bromide was stopped, TOF recovery to T2 appearance, the initial dose of sugammadex was 1 mg/kg combined with 4 μg/kg of glycopyrrolate and 0.02 mg/kg of neostigmine. An effective dose can be induced electrophysiological waveforms within 3 minutes. Otherwise, it is ineffective. The next patient is recommended to use 20% of the initial dose as a gradient to increase or decrease adjacent doses,the study ends until 8 dose inflection points are reached. Using SPSS 20 software, using Probit regression mode lto calculate ED50 and 95% confidence interval (95%CI). record HR and MAP before administration (T0) and 1 minute (T1), 3 minutes (T2), and 5 minutes (T3) after use, and intraoperative awareness, body movement rate, satisfaction with electrophysiological monitoring. RESULTS: A total of 36 patients were included in the analysis, and the Probit regression model calculated  ED50 1.338 mg/kg, 95%CI 0.838-1.786 mg/kg. The hemodynamics remained stable After administration, and the satisfaction rate of the neuroelectrophysiological monitoring doctor was 4.5±0.4. There was no intraoperative awareness or occurrence of body movements. CONCLUSION: Low dose sugammadex combined with glycopyrrolate and neostigmine can reverse muscle relaxation during intraoperative neurophysiological monitoring, with ED50 1.338 mg/kg and 95%CI 0.838-1.786 mg/kg.

Key words: sugammadex, glycopyrrolate, neostigmine, neuroelectrophysiology, median effective dose 

中图分类号: